Gibco™ Human Noggin Recombinant Protein

Catalog No.	Quantity
PHC1506	20 μg

Catalog No. PHC1506 Supplier Gibco™ Supplier No. PHC1506

Description

Recombinant Protein

Carrier-Free Reconstitution: Centrifuge the vial briefly, before opening to bring the contents to the bottom. Reconstitute the lyophilized protein in 10 mM acetic acid to a concentration of 0.1-1.0 mg/mL. Apportion the reconstituted protein into working aliquots and store at =-20°C. Make any further dilutions of the reconstituted protein in appropriate buffered solution containing a carrier protein, such as 0.1% HSA or BSA. Storage: The lyophilized protein is stable at room temperature for 3 weeks. Store at -20°C, preferably desiccated. Upon reconstitution, apportion into working aliquots and store at 4°C for 2-7 days, or at -20°C. Avoid repeated freeze-thaw cycles.

Noggin is involved in numerous developmental processes, such as neural tube fusion and joint formation. The morphogenesis of organs is initiated by a downgrowth from a layer of epithelial stem cells. This process is achieved through the receipt of signals from 1) a WNT protein (WNT3A) to stabilize beta-catenin; and 2) Noggin, which is a bone morphogenetic protein inhibitor. Noggin mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) have been identified, which have multiple joint fusion as their principal defect.

Specifications

• Accession Number: Q13253
• For Use With (Application): Bioactivity
• Formulation: Protein with no preservative
• Gene ID (Entrez): 9241
• Molecular Weight (g/mol): 46.2 kDa
• Name: Human Noggin
• Purification Method: Purified
• Quantity: 20 μg
• Storage Requirements: -20°C
• Regulatory Status: RUO
• Endotoxin Concentration: <0.1 ng/μg
• Gene Alias: NOG; Noggin; Noggin precursor; noggin; LOW QUALITY PROTEIN: noggin; SYM1; symphalangism 1 (proximal); SYNS1; SYNS1A
• Common Name: Noggin
• Gene Symbol: NOG
• Biological Activity: ED50 < 3 ng/mL; determined by the dose-depdent inhibition of alkaline phosphatase production induced by BMP-4 (5 ng/mL) in ATDC-5 chondrogenic cells.
• Product Type: Protein
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Sequence: MQHYLHIRPA PSDNLPLVDL IEHPDPIFDP KEKDLNETLL RSLLGGHYDP GFMATSPPED RPGGGGGAAG GAEDLAELDQ LLRQRPSGAM PSEIKGLEFS EGLAQGKKQR LSKKLRRKLQ MWLWSQTFCP VLYAWNDLGS RFWPRYVKVG SCFSKRSCSV PEGMVCKPSK SVHLTVLRWR CQRRGGQRCG WIPIQYPIIS ECKCSC
• Content And Storage: -20°C
• Activity: ED50 < 3 ng/mL; determined by the dose-depdent inhibition of alkaline phosphatase production induced by BMP-4 (5 ng/mL) in ATDC-5 chondrogenic cells.
• Shipping Condition: Approved for shipment on Wet or Dry Ice
• Expression System: E. coli
• Protein Form: Recombinant
• Form: Lyophilized
• Protein Subtype: Other Proteins
• Research Category: Neurobiology, Development, Stem Cell Research, Differentiation
• Product Line: Gibco
• Purity or Quality Grade: >95% by SDS-PAGE

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov